Effects of food on E7050 pharmacokinetics, and pharmacokinetics after single oral doses of 100-400mg in healthy subjects.

Trial Profile

Effects of food on E7050 pharmacokinetics, and pharmacokinetics after single oral doses of 100-400mg in healthy subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Nov 2015

At a glance

  • Drugs Golvatinib (Primary)
  • Indications Cancer
  • Focus Pharmacokinetics
  • Sponsors Eisai Co Ltd
  • Most Recent Events

    • 23 Nov 2015 Last checked against ClinicalTrials.gov record.
    • 28 Aug 2015 New source integrated ClinicalTrials.gov (NCT02533102).
    • 26 Jan 2012 Status changed from not stated to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top